|
Start-up Australia is a specialist venture capital
company which invests in innovative life science
companies which have high growth prospects. These
companies may operate in a range of sectors including;
human health, animal health, agritech and
environmental technology. As our portfolio companies have
grown in value, we have been able to deliver attractive
financial returns to our investors.
Click
here if you would like to subscribe to our quarterly
newsletter.
Latest News
Bionomics Presents new data at international conference.
Alchemia extends fondaparinux marketing
agreement with Dr Reddys.
Phase III cancer clinical trial adopted by the
NIHR in the UK.
Successful Phase I trial for anxiety drug
BNC210
Bionomics Presents BNC105 Clinical Data at
ASCO
Merck Serono extends research contract.
Second clinical trial on BNC210
commences.
HyACT technology enhances killing of cancer stem
cells.
New
Data on BNC105: Clinical marker identified.
Bionomics commences Clinical Trial in
Mesothelioma.
Collaboration to develop oral
Fondaparinux.
Clinical Trial results for BNC210.
|
